Skye Bioscience Inc

(OTO:EMBI)

Symbol has changed to a new ticker symbol

(SKYE)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Emerald Bioscience Inc is a life science biopharmaceutical company. It is engaged in the discovery, development, and the commercialization of cannabinoid-based therapeutics. The company is focused on the development of early-stage cannabinoid product candidates which includes NB1111 for the treatment of glaucoma, and NB2222 for treatment and management of several eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy; and NB3111.

Contact Information

Website: www.emeraldbio.life
Email: doug@emeraldbio.life
Main Phone: +1 949 336-3443
Address: 130 North Marina Drive
Address 2: Suite 1100
State: CA
City / Town: Long Beach
Country: US
Postal Code: 90803

Issuer Information

Exchange: OTO
CEO: Brian S. Murphy
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A